In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children
- 29 November 2001
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 18 (6) , 531-535
- https://doi.org/10.1016/s0924-8579(01)00462-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mutation in 23S rRNA Responsible for Resistance to 16-Membered Macrolides and Streptogramins in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- The in vitro activity of ABT773, a new ketolide antimicrobial agent.Journal of Antimicrobial Chemotherapy, 2000
- Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and ClarithromycinClinical Infectious Diseases, 2000
- Limiting the Spread of Resistant Pneumococci: Biological and Epidemiologic Evidence for the Effectiveness of Alternative InterventionsClinical Microbiology Reviews, 2000
- The new antibacterial class: The ketolidesClinical Microbiology Newsletter, 2000
- Antipneumococcal Activity of ABT-773 Compared to Those of 10 Other AgentsAntimicrobial Agents and Chemotherapy, 2000
- Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis.Journal of Antimicrobial Chemotherapy, 2000
- Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibioticsJournal of Antimicrobial Chemotherapy, 1999
- Susceptibilities of Penicillin- and Erythromycin-Susceptible and -Resistant Pneumococci to HMR 3647 (RU 66647), a New Ketolide, Compared with Susceptibilities to 17 Other AgentsAntimicrobial Agents and Chemotherapy, 1998
- Novel mechanism of macrolide resistance in Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 1996